SharadKhuranaMDMSc

Hematology • Tucson, AZ

Hematologic Oncology

Assistant Professor of Medicine

Join to view full profile

Dr. Khurana is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Khurana's full profile

Already have an account?

Office
3838 N Campbell Ave
Tucson, AZ 85719
Phone+1 520-694-2873

Summary

Bone Marrow Transplant/Cellular Therapist with focus on Acute myeloid/lymphoid Leukemias and myeloid disorders.

Education & Training

Mayo Clinic College of Medicine and Science (Jacksonville)Fellowship, Hematology and Medical Oncology, 2017 - 2020
Rush UniversityMSc, Clinical Research, 2015 - 2017
Cook County Health and Hospitals SystemResidency, Internal Medicine, 2014 - 2017
Grant Medical CollegeClass of 2013

Certifications & Licensure

AZ State Medical License 2020 - 2027
FL State Medical License 2017 - 2021
IL State Medical License 2014 - 2017
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage Start of enrollment: 2019 Nov 22
Recruiting
Phase 3
A Study of TAS1440 With ATRA in Subjects With r/r AML Start of enrollment: 2020 Mar 15
Active, not recruiting
Phase 1
Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome Start of enrollment: 2021 Feb 08
Recruiting
Phase 3
A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML) Start of enrollment: 2020 Feb 26
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Clinical, Phenotypic and Molecular Characterization ofFusion Positive Myeloid Malignancies.
Chelby Wakefield, Mary Hansen Smith, Ulyana Dashkevych, Maria Proytcheva, Sharad Khurana
Journal of Medical Cases. 2024-09-01
Evaluation of Novel Targets, Including CC-Chemokine Receptor 4, in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma: A Mayo Clinic Clinical and Pathologic Study.
Sharad Khurana, Michael G Heckman, Fiona E Craig, Jordan J Cochuyt, Patricia Greipp
Archives of Pathology & Laboratory Medicine. 2024-04-01
Refractory Pure Red Blood Cell Aplasia Secondary to Major ABO-Incompatible Allogeneic Stem Cell Transplantation Successfully Treated With Daratumumab.
Clinton Wu, Pete Manchen, Ariela Edelman, Muhammad Husnain, Emmanuel Katsanis
Journal of Hematology. 2023-12-01

Abstracts/Posters

Incidence and Outcomes of Cardiovascular Disease in Hemophilia Patients: An Analysis of National Inpatient Sample Database
Sharad Khurana, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Impact of Targeted Immunotherapies and Novel Cytogenetic and Clinical Risk Groups on Outcome after Allogeneic Hematopoietic Stem Cell Transplant (AlloHCT) for Acute Ly...
Sharad Khurana, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Professional Memberships

American Society of Clinical Oncologists - ASCO
Member
American Society of Hematology - ASH
Member